Expanding Beyond Service Offering, Metabolon Adds Diagnostics to Business

At the end of June, the company anticipates launching its first test, for insulin-resistance, with prostate cancer tests targeted for the end of the year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories